Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Treatment of Chronic Idiopathic Systemic Vasculitides

  • Chapter
ANCA-Associated Vasculitides

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 336))

  • 193 Accesses

Summary

The following review is intended to summarize currently accepted, as well as newly appreciated therapies for the chronic systemic vasculitides. In recent years, a great deal has been learned about enhancement and inhibition of immunoinflammatory phenomena. Biological, immunomodulatory agents with focussed actions are just beginning to be tested in the clinical setting. However, until these promising approaches have been more thoroughly evaluated, it will continue to be necessary to cautiously titrate broadly immunosuppressive medications for the treatment of these disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. G.S. Hoffman and G.S. Kerr, Recognition of systemic vasculitis in the acutely ill patient, In: “Management of Critically Ill Patients with Rheumatologic and Immunologic Diseases,” B.F. Mandell, ed., Marcel Dekker, Inc. (1993).

    Google Scholar 

  2. P.P. Frohnert and S.G. Sheps, Longterm follow-up study of polyarteritis nodosa, AmJMed. 43: 8–14 (1967).

    Google Scholar 

  3. E.S. Leib, C. Restivo, and H.E. Paulus, Immunosuppressive and corticosteroid therapy of polyarteritis nodosa, Am JMed 67: 941 (1979).

    CAS  Google Scholar 

  4. R.D. Cohen, D.L. Conn, and D.M. Ilstrup, Clinical features, prognosis and response to treatment in polyarteritis, Mayo Clin Proc. 55: 146 (1980).

    PubMed  CAS  Google Scholar 

  5. L. Guillevin, L.T.H. Du, P. Godeau, P. Jais, and B. Wechsler, Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss angiitis: a study of 165 patients, Brit J Rheumatol 27: 258 (1988).

    Article  CAS  Google Scholar 

  6. L. Guillevin, and The Cooperative Study Group for the study of polyarteritis nodosa: Treatment of polyarteritis nodosa and Churg-Strauss angiitis: indication of plasma exchange results of three prospective trials in 162 patients, Apheresis. 337: 309 (1990).

    CAS  Google Scholar 

  7. L. Guillevin, B. Jarrousse, C. Lok, F. Lhote, J.P. Jais, L.T.H. Du, A. Busse], et al., Longterm followup after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange, and cyclophosphamide to steroids and plasma exchange, A prospective randomized trial of 71 patients, JRheumatol. 18: 567 (1991).

    CAS  Google Scholar 

  8. R.A. Lugmani, M. Gordon, I. Greaves, D. Adu, J. Michael, P. Emery, and P.A. Bacon, Necrotizing vasculitis-relapse despite cytotoxic therapy, Arthritis Rheum. 34: S51 (1991).

    Google Scholar 

  9. C. Trepo, D. Ouzan, J. Delmont, and J. Tremisi, Supé riorité d’une nouveau traitement étiopathogé nique curateur des périartérities noueuses induites par le virus de d’hé patite B grâce à l’association corticothérapie brève, vidarabine, échanges plasmatiques, La Presse Méd. 30: 1527 (1988).

    Google Scholar 

  10. L. Guillevin, Y. Merrouche, M. Gayraud, B. Jarrousse, I. Royer, A. Léon, and J. Baudelot, Périarterite noueuse lié e au virus de hépatite B. Détermination d’une stratégie therapeutique nouvelle: 13 observations, La Press Méd. 17: 1522 (1988).

    CAS  Google Scholar 

  11. C.W. Carson, D.L. Conn, A.J. Czaja, and M.E. Brecher, Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa, Arthritis Rheum. 34: 891 (1991).

    Google Scholar 

  12. R.D. Inman, M. Hodge, M.E.A. Johnston, J. Wright, and J. Heathcote, Arthritis, vasculitis and cryoglobulinemia associated with relapsing hepatitis A infection, Ann Intern Med. 105: 700 (1986).

    Article  PubMed  CAS  Google Scholar 

  13. A. Banji and R. Salisbury, Cytomegalovirus and vasculitis, Brit Med J. 1: 623 (1978).

    Article  Google Scholar 

  14. Z.D. Goodman, J.K. Boitrott, and J.H. Yardley, Perforation of the colon associated with cytomegalovirus infection, Digest Dis Sei. 24: 376 (1979).

    Article  CAS  Google Scholar 

  15. M. Doherty and J.W.B. Bradfield, Polyarteritis nodosa associated with acute cytomegalovirus infection, Ann Rheum Dis. 40: 419 (1981).

    Article  PubMed  CAS  Google Scholar 

  16. P.R. Phinney, S. Fligiel, Y.J. Bryson, and D.D. Porter, Necrotizing vasculitis in a case of disseminated neonatal herpes simplex infection, Arch Pathol Lab Med. 106: 64 (1982).

    PubMed  CAS  Google Scholar 

  17. G.S. Hoffman and W.A. Franck, Infectious mononucleosis, autoimmunity and vasculitis, JAMA. 241: 2735 (1979).

    Article  PubMed  CAS  Google Scholar 

  18. L.H. Calabrese, M. Estes, B. Yen-Lieberman, M.R. Proffitt, R. Tubbs, A.J. Fishleder, and K.H. Levin, Systemic vasculitis in association with human immunodeficiency virus infection, Arthritis Rheum. 32: 569 (1989).

    Article  PubMed  CAS  Google Scholar 

  19. E.W. Walton, Giant cell granuloma of the respiratory tract (Wegener’s granulomatosis), Brit Med J. 2: 265 (1958).

    Article  PubMed  CAS  Google Scholar 

  20. G.S. Hoffman, G.S. Kerr, R.Y. Leavitt, C.W. Hallahan, R.S. Lebovics, W.D. Travis, M. Rottem, and A.S. Fauci, Wegener’s granulomatosis: an analysis of 158 patients, Ann Intern Med. 116: 488 (1992).

    Article  PubMed  CAS  Google Scholar 

  21. A.S. Fauci and S.M. Wolff, Wegener’s granulomatosis: studies in eighteen patients and a review of the literature, Medicine. 52: 535 (1973).

    Article  PubMed  CAS  Google Scholar 

  22. A.S. Fauci, B.F. Haynes, P. Katz, and S.M. Wolff, Wegener’s granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years, Ann Intern Med 98: 76 (1983).

    Article  PubMed  CAS  Google Scholar 

  23. R.J. Falk, S. Hogan, J.C. Jennette, and The Glomerular Disease Collaborative Network, Clinical course of antineutrophil cytoplasmic antibody associated glomerulonephritis and systemic vasculitis, Ann Intern Med. 113: 656 (1990).

    Article  PubMed  CAS  Google Scholar 

  24. G.S. Hoffman, R.Y. Leavitt, T.A. Fleisher, J.R. Minor, and A.S. Fauci, Treatment of Wegener’s granulomatosis with intermittent high-dose intravenous cyclophosphamide, Am JMed. 89: 403 (1990).

    CAS  Google Scholar 

  25. D. Steppat and W.L. Gross, Stage adapted treatment of Wegener’s granulomatosis, Klin Wochenschr. 67: 666 (1989).

    Article  PubMed  CAS  Google Scholar 

  26. R.A. DeRemee, T.J. McDonald, and L.H. Weiland, Wegener’s granulomatosis: observations on treatment with antimicrobial agents, Mayo Clin Proc. 60: 27 (1985).

    Article  PubMed  CAS  Google Scholar 

  27. H.L. Israel. Sulfamethoxazole-trimethoprim therapy for Wegener’s granulomatosis, Arch Intern Med. 148: 2293 (1988).

    Article  PubMed  CAS  Google Scholar 

  28. G.S. Hoffman, R.Y. Leavitt, G.S. Kerr, A.S. Fauci, The treatment of Wegener’s granulomatosis with glucocorticoids and methotrexate. Arthritis Rheum. 35: 1322 (1992).

    PubMed  CAS  Google Scholar 

  29. D.R.W. Jayne, M.J. Davies, C.J.V. Fox, C.M. Black, and C.M. Lockwood, Treatment of systemic vasculitis with pooled intravenous immunoglobulin, Lancet. 337: 1137 (1991).

    Article  PubMed  CAS  Google Scholar 

  30. J.H. Shelhamer, D.J. Volkman, J.E. Parillo, et al., Takayasu’s arteritis and its therapy, Ann Intern Med. 103: 121 (1985).

    Article  PubMed  CAS  Google Scholar 

  31. G.S. Hoffman, R.Y. Leavitt, G.S. Kerr, M. Rottem, and A.S. Fauci, Treatment of Takayasu’s arteritis with methotrexate, Arthritis Rheum. 34: 874 (1991).

    Article  Google Scholar 

  32. P. Lagneau, J.B. Michel, and P.N. Vuong, Surgical treatment of Takayasu’s disease, Ann Surg. 205: 157 (1987).

    Article  PubMed  CAS  Google Scholar 

  33. E. Kieffer, A. Piquois, A. Bertal, O. Beetry, and P. Godeau, Reconstructive surgery of the renal arteries in Takayasu’s disease, Ann VaseSurg. 4: 156 (1990).

    CAS  Google Scholar 

  34. J.M. Giordano, R.Y. Leavitt, G.S. Hoffman, and A.S. Fauci, Experience with surgical treatment of Takayasu’s disease, Surgery. 109: 252 (1991).

    PubMed  CAS  Google Scholar 

  35. K. Ishikawa. Natural history and classification of occlusive thromboaortopathy (Takayasu’s disease), Circulation. 57: 27 (1978).

    Article  PubMed  CAS  Google Scholar 

  36. K. Ishakawa, Survival and morbidity after diagnosis of occlusive thromboaortopathy (Takayasu’s disease), Am J Cardiology. 47: 1026 (1981).

    Article  Google Scholar 

  37. J.M. Dwyer, Manipulating the immune system with immune globulin, NEngIJMed. 326: 107 (1992).

    Google Scholar 

  38. J.W. Newburger, M. Takahashi, J.C. Burns, A.S. Beiser, K.J. Chung, E. Duffy, M.P. Glade, et al., The treatment of Kawasaki syndrome with intravenous gamma globulin, NEngl JMed. 315: 341 (1986).

    Article  CAS  Google Scholar 

  39. J.W. Newberger, M. Takahashi, A.S. Beiser, J.C. Burns, J. Bastian, K.J. Chung, et al., A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome, NEngIJMed. 324: 1633 (1991).

    Article  Google Scholar 

  40. K. Furusho, H. Nakano, K. Shinomiya, T. Tamura, Y. Manabe, M. Karvarano, K. Baba, et al., High-dose intravenous gamma globulin for Kawasaki Disease, Lancet. 2: 1055 (1984).

    Article  PubMed  CAS  Google Scholar 

  41. H. Becker, G. Mitropoulou, and K. Helmke, Immunomodulating therapy in rheumatoid arthritis by high dose intravenous immunoglobulin, Klin Wochenschr. 67: 286 (1989).

    Article  PubMed  CAS  Google Scholar 

  42. P. Cheringelfand, S. Herson, B. Wechsler, J.-C. Piette, O. Bletry, A. Coutellier, J.-M. Ziza, Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients, Am JMed. 91: 162 (1991).

    Google Scholar 

  43. E.W. Gelfand, The use of intravenous immune globulin in collagen vascular disorders: A potentially new modality of therapy, JAllergy Clin Immunol 84: 613, (1989).

    Article  CAS  Google Scholar 

  44. B.A. Lang, R.M. Laxer, G. Murphy, E.D. Silverman, and C. Roifman, Treatment of dermatomyositis with intravenous gammaglobulin, Am JMed 91: 169 (1991).

    CAS  Google Scholar 

  45. G.E. Grau, P. Roux-Lombard, C. Gysler, C. Lambert, P.H. Lambert, J.M. Dayer, L. Guillevin, Serum cytokine changes in systemic vasculitis, Immunology. 68: 196 (1989).

    PubMed  CAS  Google Scholar 

  46. Y. Deguchi, N. Shibata, and S. Kishimoto, Enhanced expression of the tumour necrosis factor/cachectic gene in peripheral blood mononuclear cells from patients with systemic vasculitis, Clin Exp Immunol. 81: 311 (1990).

    Article  PubMed  CAS  Google Scholar 

  47. D. Wofsy and W.E. Seaman, Reversal of advanced immune lupus in NZB/NZW Fl mice by treatment with monoclonal antibody to L3T4, Jlmmunol 138: 3247 (1987).

    CAS  Google Scholar 

  48. P.W. Mathieson, S.P. Cobbold, G. Hale, M.R. Clark, D.B.G. Oliveira, C.M. Lockwood, and H. Waldmann, Monoclonal-antibody therapy in systemic vasculitis, NEngl JMed. 323: 250 (1990).

    Article  CAS  Google Scholar 

  49. C. Herzog, C. Wallur, W. Pichler, A. Aeschlimann, et al., Monoclonal anti-CD4 in arthritis, Lancet. 2: 1461 (1987).

    Article  PubMed  CAS  Google Scholar 

  50. K.J. Tracey, Y. Fong, D.G. Hesse, K.R. Manogue, A.T. Lee, G.C. Kuo, S.F. Lowry, and A. Ceramie, Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia, Nature. 330: 662 (1987).

    Article  PubMed  CAS  Google Scholar 

  51. R.D. Mayforth and J. Quintans, Designer and catalytic antibodies, NEngl JMed. 323: 173 (1990).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Vasculitis and Related Diseases Section Laboratory of Immunoregulation National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA

    Gary S. Hoffman (Head, Chairman)

Authors
  1. Gary S. Hoffman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medical University of Lübeck, Lübeck, Germany

    Wolfgang L. Gross

  2. Rheumaklinik Bad Bramstedt GmbH, Bad Bramstedt, Germany

    Wolfgang L. Gross

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media New York

About this chapter

Cite this chapter

Hoffman, G.S. (1993). Treatment of Chronic Idiopathic Systemic Vasculitides. In: Gross, W.L. (eds) ANCA-Associated Vasculitides. Advances in Experimental Medicine and Biology, vol 336. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9182-2_33

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9182-2_33

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-9184-6

  • Online ISBN: 978-1-4757-9182-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation